Correlation Between Craniovertebral Angle and Temporomandibular Disorders

April 4, 2026 updated by: Mohamed Mahmoud Mousa, Cairo University
The purpose of study was investigate the correlation between craniovertebral angle and Temporomandibular disorders.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Individuals with forward head posture (FHP) were three times more likely to develop temporomandibular disorder (TMD) compared to those with normal posture. It was discovered that improper head and cervical position was present in almost 70% of TMD participants. Participants with TMD were especially likely to have a forward-leaning head posture. Recommended postural testing as part of TMD evaluation, implying that postural disorders may cause or worsen TMD symptoms FHP is characterized as the cervical spine held in a protracted position for a prolonged duration; it can lead to alterations in head posture, ultimately leading to poor posture, which is thought to be a deviation from neutral or normal posture.

There is evidence from certain studies that people with TMDs have altered head and cervical spine posture, while no such link is found in other investigations. The skull, mandible, and cervical spine exhibit neurological and biomechanical connections, generating a functional complex that may be referred to as the "Cranio Cervical Mandibular system," which is related to the cervical area via muscles and ligaments.

TMD symptoms and cervical dysfunction are strongly correlated, supporting combined evaluation, and this will significantly aid in the treatment of participants with temporomandibular joint dysfunction and forward head posture.

Study Type

Observational

Enrollment (Actual)

68

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Mohamed Mahmoud Mousa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Sixty-eight male and female participants aged between 18 and 40 years. All participants demonstrated measurable forward head posture, defined as a craniovertebral angle less than 50°, assessed using Kinovea software.

Description

Inclusion Criteria:

  • Male and female with body mass index (18.5-29.9 kg/m2).
  • Chronic temporomandibular joint dysfunction symptoms persisting for at least 3 months, with a cut-off point score of the Fonseca's Anamnestic Index of 20 points or more
  • Craniovertebral angle (CVA) of less than 50°.
  • Participants must exhibit measurable FHP, defined as a craniovertebral angle (CVA) <50°, assessed using Kinovea software.
  • Participant has mouth opening less than 40mm.
  • Participants haven't received any physiotherapy sessions on cervical or temporomandibular joint in last 6 weeks, nor have taken any non- steroidal anti-inflammatory drugs (NSAIDs) for the last two weeks preceding the study.

Exclusion Criteria:

  • The subjects were excluded if they were unable to fulfil the inclusion criteria and if they had a history of any of the following:
  • History of acute head, neck, or Temporomandibular joint trauma or any surgical intervention in these regions within the past 6 months.
  • Congenital temporomandibular joint abnormalities.
  • Participants with congenital deformities of the head and the neck.
  • Participants with systemic diseases, such as rheumatoid arthritis.
  • Participants received physical therapy or other conservative treatments for neck pain, temporomandibular disorders, or postural correction within the past 3 months.
  • Major psychiatric disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Forward head posture group
Sixty-eight male and female participants aged between 18 and 40 years. All participants demonstrated measurable FHP, defined as a CVA of less than 50°, assessed using Kinovea software.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Craniovertebral Angle (CVA) assessment
Time Frame: 8 weeks
The CVA was measured using digital image analysis of a lateral- view photograph of each participant seated in the same standard chair. Participants were instructed to adopt a relaxed posture, ensuring that the thoracic and lumbar regions contact the backrest, their gaze was directed toward the horizon, and both feet rest flat on the floor with knees flexed at 90°. A camera was positioned one meter from the participant on a level tripod at shoulder height. A marker was affixed with adhesive tape at the level of the C7 vertebra, ensuring that the participant's ear tragus remains visible within the photo frame. Identification of the C7 vertebra was conducted using active cervical rotation as described elsewhere. The image was analyzed using Kinovea 0.8.15 software, defining the craniovertebral angle as the angle formed between a horizontal line and the line connecting the spinous process of C7 to the ear's tragus. FHP is defined as CVA <50°.
8 weeks
Fonseca questionnaire for temporomandibular disorders (TMDs) assessment
Time Frame: 8 weeks
The Arabic version of Fonseca's questionnaire was used for screening temporomandibular disorders (TMDs). The questionnaire consists of 10 questions, each question having a three-point scale. For each question, the participants were instructed that only one answer was marked: "yes" (10 points), "no" (0 points), and "maybe" (5 points). Based on the sum of their points, the individuals were classified as the TMD- free (0-15), mild TMD (20-40), moderate TMD (45-60), and severe TMD (70-100).
8 weeks
Temporomandibular joint opening
Time Frame: 8 weeks
The TheraBite Jaw Motion Rehabilitation System was used to assess temporomandibular opening range. The participant was asked to open their mouth as wide as possible. The TheraBite scale was placed between the central incisors to measure the maximum vertical distance during active mouth opening. The scale is a disposable paper measurement tool used to assess maximum mouth opening (MMO) in millimeters (mm)
8 weeks
Temporomandibular joint lateral excursions
Time Frame: 8 weeks
The TheraBite Jaw Motion Rehabilitation System was used to assess temporomandibular-lateral excursion range. The participant will be seated with a neutral head position. Initially, the examiner will align the scale's reference mark with the midline of the upper central incisors. Next, the participant will be instructed to move their mandible laterally; first to the right and then to the left, as far as comfortably possible without inducing pain. The lateral excursion will then be quantified by measuring the horizontal distance (in millimeters) between the upper midline and the new position of the lower incisor midline.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hussein Khalil, Sinai university
  • Study Chair: Nasr Abdelkader, Professor, Cairo university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2025

Primary Completion (Actual)

January 20, 2026

Study Completion (Actual)

January 30, 2026

Study Registration Dates

First Submitted

April 4, 2026

First Submitted That Met QC Criteria

April 4, 2026

First Posted (Actual)

April 13, 2026

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 4, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Joint Disorders

Subscribe